Issued Patents All Time
Showing 1–25 of 32 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12428376 | Therapeutic compounds and compositions | Francesco G. Salituro, Jeffrey O. Saunders | 2025-09-30 |
| 12419854 | Methods for treating or preventing gout or hyperuricemia | Litain YEH, Rongzi YAN | 2025-09-23 |
| 12145917 | Crystalline forms of a compound for treating or preventing gout or hyperuricemia | Litain YEH, Zheng Li, Ruiping Wang | 2024-11-19 |
| 11866411 | Therapeutic compounds and compositions | Francesco G. Salituro, Jeffrey O. Saunders | 2024-01-09 |
| RE49582 | Therapeutic compounds and compositions | Francesco G. Salituro, Jeffrey O. Saunders | 2023-07-18 |
| 11505538 | Therapeutically active compounds and their methods of use | Giovanni Cianchetta, Byron DeLaBarre, Janeta Popovici-Muller, Francesco G. Salituro, Jeffrey O. Saunders +3 more | 2022-11-22 |
| 11236058 | Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemia | Li-Tain Yeh, Robert ORR | 2022-02-01 |
| 10988448 | Therapeutic compounds and compositions | Francesco G. Salituro, Jeffrey O. Saunders | 2021-04-27 |
| 10508093 | Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemia | Li-Tain Yeh, Robert ORR | 2019-12-17 |
| 10414740 | Glutaminase inhibitors and method of use | Rene Lemieux, Janeta Popovici-Muller, Francesco G. Salituro, Jeffrey O. Saunders, Jeremy Travins | 2019-09-17 |
| 10294215 | Therapeutically active compounds and their methods of use | Giovanni Cianchetta, Byron DeLaBarre, Janeta Popovici-Muller, Francesco G. Salituro, Jeffrey O. Saunders +3 more | 2019-05-21 |
| 10239854 | Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemia | Li-Tain Yeh, Robert ORR | 2019-03-26 |
| 10202339 | Therapeutic compounds and compositions | Janeta Popovici-Muller, Francesco G. Salituro, Jeffrey O. Saunders, Jeremy Travins | 2019-02-12 |
| 10029987 | Therapeutic compounds and compositions | Francesco G. Salituro, Jeffrey O. Saunders | 2018-07-24 |
| 10011574 | Glutaminase inhibitors and method of use | Rene Lemieux, Janeta Popovici-Muller, Francesco G. Salituro, Jeffrey O. Saunders, Jeremy Travins | 2018-07-03 |
| 9856279 | Therapeutically active compositions and their methods of use | Sheldon Cao, Janeta Popovici-Muller, Francesco G. Salituro, Jeffrey O. Saunders, Xuefei Tan +2 more | 2018-01-02 |
| 9732062 | Therapeutically active compounds and their methods of use | Giovanni Cianchetta, Byron DeLaBarre, Janeta Popovici-Muller, Francesco G. Salituro, Jeffrey O. Saunders +3 more | 2017-08-15 |
| 9708326 | Inhibitors of bruton's tyrosine kinase | Wei Chen, David J. Loury, Leah L. Frye, Jeremy Robert Greenwood, Mee Shelley +1 more | 2017-07-18 |
| 9662327 | Phenyl and pyridinyl substituted piperidines and piperazines as inhibitors of IDH1 mutants and their use in treating cancer | Sheldon Cao, Janeta Popovici-Muller, Francesco G. Salituro, Jeffrey O. Saunders, Xuefei Tan +2 more | 2017-05-30 |
| 9656999 | Therapeutically active compounds and their methods of use | Giovanni Cianchetta, Byron DeLaBarre, Janeta Popovici-Muller, Francesco G. Salituro, Jeffrey O. Saunders +3 more | 2017-05-23 |
| 9580416 | Inhibitors of Bruton's tyrosine kinase | Wei Chen, Longcheng Wang, David J. Loury, Zhaozhong J. Jia, Leah L. Frye +6 more | 2017-02-28 |
| 9512107 | Therapeutically active compositions and their methods of use | Giovanni Cianchetta, Byron DeLaBarre, Janeta Popovici-Muller, Francesco G. Salituro, Jeffrey O. Saunders +3 more | 2016-12-06 |
| 9469642 | Purinone compounds as kinase inhibitors | Wei Chen, David J. Loury, Longcheng Wang, Leah L. Frye | 2016-10-18 |
| 9303002 | Compounds and their methods of use | Rene Lemieux, Janeta Popovici-Muller, Francesco G. Salituro, Jeffrey O. Saunders, Jeremy Travins | 2016-04-05 |
| 9221792 | N-(4-(azetidine-1-carbonyl) phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase M2 (PMK2) modulators | Francesco G. Salituro, Jeffrey O. Saunders | 2015-12-29 |